Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

Moore, Malcolm J

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology May 2007 - 1960-6 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2006.07.9525 doi


Adenocarcinoma--drug therapy
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Deoxycytidine--administration & dosage
Double-Blind Method
Erlotinib Hydrochloride
Female
Humans
International Agencies
Male
Middle Aged
Pancreatic Neoplasms--drug therapy
Placebos
Prognosis
Quinazolines--administration & dosage
Survival Rate
Treatment Outcome
Gemcitabine